Please use this identifier to cite or link to this item: http://hdl.handle.net/10603/333098
Title: Design development and evaluation of gastro retentive drug delivery system by incorporation of nanoparticles or microspheres
Researcher: Ayre Anita Pandurang
Guide(s): Lalitha K G
Keywords: Design development
Gastro Retentive Drug Delivery System
Nanoparticles, Microspheres
University: The Tamil Nadu Dr. M.G.R. Medical University
Completed Date: 2014
Abstract: In view of formulating gastro retentive sustained release dosage form, we have successfully encapsulated the two drugs famotidine and captopril by different techniques. Modified spontaneous emulsification- solvent diffusion was used for the generation of famotidine loaded PLGA nanoparticles wherein mucoadhesion was attained by using Carbopol as the mucoadhesive polymer. On the other hand ernulsification- solvent diffusion encapsulating captopril into porous carrier calcium silicate with the aid of matrix forming polymer Eudragit S 100 was used for the generation of floating microspheres of captopril. Farnotidine (FAM) is an I-12-receptor blocker used to treat duodenal ulcers, Zollinger-Ellison syndrome and reflux oesophagitis. It is classified as a BCS class IV drug, i.e. it is poorly water soluble, making it an ideal candidate for improving its solubility by particle size reduction. It has higher solubility in acidic medium and studies have been conducted which demonstrated the effectiveness of retaining FAM in the stomach, thus justifying its formulation into a gastroretentive dosage form. FAM has a dose of 20- 40 mg and a short half life, thereby justifying its development into a sustained release formulation. Thus famotidine was an ideal candidate to be formulated as a combined drug delivery system which encompassed the advantages of sustained release, gastroretentive, nanoparticulate system. newlineCaptopril, is an ACE inhibitor, i.e. anti-hypertensive drug. It belongs to Class III category. Also the drug has an absorption window in the stomach. In order to prevent burst release, mu ltiparticluate in the form of microspheres was adopted as a technique to formulate microspheres of CAP. In conclusion, it can be said that combining various strategies has shown an improvement in the bioavailability of FAN /I and CAP effectively. The strategies employed, excipients and equipments are routinely used and can very easily be scaled up. Thus it can be conclusively said that the goals envisaged have been fulfilled.
Pagination: 301
URI: http://hdl.handle.net/10603/333098
Appears in Departments:Department of Pharmacy

Files in This Item:
File Description SizeFormat 
01_title.pdf.pdfAttached File14.96 kBAdobe PDFView/Open
02_certificate.pdf491.81 kBAdobe PDFView/Open
03_preliminary pages.pdf953.71 kBAdobe PDFView/Open
04_chapter 1.pdf2.51 MBAdobe PDFView/Open
05_chapter 2.pdf1.33 MBAdobe PDFView/Open
06_chapter 3.pdf250.51 kBAdobe PDFView/Open
07_chapter 4.pdf113.31 kBAdobe PDFView/Open
08_chapter 5.pdf12.79 MBAdobe PDFView/Open
09_chapter 6.pdf7.25 MBAdobe PDFView/Open
10_bibliography.pdf1 MBAdobe PDFView/Open
11_appendix.pdf7.46 MBAdobe PDFView/Open
80_recommendation.pdf317.31 kBAdobe PDFView/Open
Show full item record


Items in Shodhganga are licensed under Creative Commons Licence Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0).

Altmetric Badge: